CorMedix Inc.

Historical 13F Holders

Symbol
CRMD
CUSIP
21900C308
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 21900C308 since 12/18/2024, newest first.

Filer % of Class Filed
Shaibatalhamd Aymen Abdalkader 13G/A Amendment 5 5.9% 6/12/2026
Event 6/11/2026
Shaibatalhamd Aymen Abdalkader 13G/A Amendment 4 5.9% 6/12/2026
Event 6/11/2026
Deep Track Capital, LP 13G/A Amendment 1
7.9% 5/15/2026
Event 3/31/2026
Vanguard Group Inc 13G/A Amendment 1 0% 3/26/2026
Event 3/13/2026
Shaibatalhamd Aymen Abdalkader 13G/A Amendment 3 5.8% 1/2/2026
Event 1/1/2026
Deep Track Capital, LP 13G
6.3% 12/1/2025
Event 11/21/2025
Shaibatalhamd Aymen Abdalkader 13G/A Amendment 2 6.2% 8/8/2025
Event 8/8/2025
Shaibatalhamd Aymen Abdalkader 13G/A Amendment 1 0% 5/12/2025
Event 5/8/2025
Shaibatalhamd Aymen Abdalkader 13G 5.4% 4/4/2025
Event 3/25/2025
BlackRock, Inc. 13G/A Amendment 1 7.5% 2/5/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 1.90 k $14.6 k
2026 Q2 204 44.6 M $421 M
2026 Q1 201 41.2 M $280 M
2025 Q4 211 42.0 M $488 M
2025 Q3 199 43.2 M $503 M
2025 Q2 183 34.5 M $425 M
2025 Q1 148 23.8 M $146 M
2024 Q4 137 23.0 M $185 M
2024 Q3 110 19.3 M $155 M
2024 Q2 107 17.5 M $74.9 M
2024 Q1 99 17.7 M $74.2 M
2023 Q4 110 19.1 M $71.0 M
2023 Q3 97 17.9 M $65.5 M
2023 Q2 95 19.2 M $75.6 M
2023 Q1 74 10.8 M $44.1 M
2022 Q4 74 11.5 M $47.7 M
2022 Q3 80 11.0 M $31.3 M
2022 Q2 83 15.4 M $60.8 M
2022 Q1 92 13.4 M $73.4 M
2021 Q4 90 13.2 M $60.0 M
2021 Q3 85 11.8 M $55.0 M
2021 Q2 89 11.4 M $78.0 M
2021 Q1 88 10.9 M $109 M
2020 Q4 86 9.37 M $69.6 M
2020 Q3 79 8.33 M $50.2 M
2020 Q2 76 6.74 M $42.5 M
2020 Q1 64 6.62 M $23.7 M
2019 Q4 68 6.75 M $49.1 M
2019 Q3 60 6.47 M $41.3 M
2019 Q2 58 5.61 M $50.3 M
2019 Q1 46 3.66 M $34.6 M